Beverly L. Davidson

Dr. Davidson has contributed extensively to our understanding of the molecular basis of neurodegenerative diseases and advancing new therapeutic approaches for their treatment. Her studies encompass lysosomal storage diseases and the dominantly inherited polyglutamine disorders, e.g., Huntington's disease. She provided fundamental work demonstrating that the pathology and functional impairments were reversible in animal models, including designing new tools and therapeutic approaches. She was also the first to engineer gene silencing methods for mammalian brain. Her expertise in molecular and viral technology provides a foundation for future experimental therapies aimed at treating patients suffering from these fatal disorders.